Article
Genetics of melanoma tumorigenesis.
The British journal of dermatology - 1 Jan 2008
Singh M, Lin J, Hocker T L, Tsao H
Abstract excerpt
Melanoma therapy is moving away from combinatorial approaches and towards newer targeted strategies. With the identification of mutations in various RAS pathway genes, there are now tremendous opportunities to bring inhibitors of RAS signalling to the clinical arena.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
